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Abstract The in vivo accessibility of the chick embryo makes it a favoured model 
system for experimental developmental biology. Although the range of 
available techniques now extends to miss-expression of genes through in ovo 
electroporation, it remains difficult to knock out individual gene expression. 
Recently, the possibility of silencing gene expression by RNAi in chick 
embryos has been reported. However, published studies show only discrete 
quantitative differences in the expression of the endogenous targeted genes 
and unclear morphological alterations. To elucidate whether the tools 
currently available are adequate to silence gene expression sufficiently to 
produce a clear and specific null-like mutant phenotype, we have performed 
several experiments with different molecules that trigger RNAi: dsRNA, 
siRNA, and shRNA produced from a plasmid coexpressing green fluorescent 
protein as an internal marker. Focussing on fgf8 expression in the developing 
isthmus, we show that no morphological defects are observed, and that fgf8 
expression is neither silenced in embryos microinjected with dsRNA nor in 
embryos microinjected and electroporated with a pool of siRNAs. Moreover, 
fgf8 expression was not significantly silenced in most isthmic cells 
transformed with a plasmid producing engineered shRNAs to fgf8. We also 
show that siRNA molecules do not spread significantly from cell to cell as 
reported for invertebrates, suggesting the existence of molecular differences 
between different model systems that may explain the different responses to 
RNAi. Although our results are basically in agreement with previously 
reported studies, we suggest, in contrast to them, that with currently 
available tools and techniques the number of cells in which fgf8 gene 
expression is decreased, if any, is not sufficient to generate a detectable 
mutant phenotype, thus making RNAi useless as a routine method for 
functional gene analysis in chick embryos. 
Key words RNA interference (RNAi), small interfering RNA (siRNA), short hairpin RNA 
(shRNA), chick embryo, isthmus, fgf8 
Author 
biography 
David Bueno (Barcelona, 1965) received PhD in Genetics in 1994 for work on 
planarian regeneration at cellular and molecular level. His PhD thesis was awarded 
cum laude and PhD Extraordinary Award. He did postdoctoral work at the 
University of Oxford, focused on the analysis of Fibroblast Growth Factor functions 
during vertebrate development, using transgenic mice as a model system. Since 1996 
he has worked at the Department of Genetics of the University of Barcelona and 
became a Lecturer in 2003. He is a founder member of Spanish Society of 
Developmental Biology. His current research focuses on central nervous system 
development and neuronal proliferation and differentiation in vertebrates, analysing 
molecules involved in these processes that may also be involved in human 
neurodegenerative diseases. He is author or co-author of over 28 articles in peer-
review journals, 35 papers to international congresses, and 2 chapters in books.  
Victor Hernández Hernández (Barcelona, 1973) received Master degree in 
Experimental Biology from the UB in 2001. The same year he started the PhD studies 
in the Department of Genetics, working on genes involved in the development of the 
central nervous system in chick embryos. He is author or co-author of 6 articles on 
planarian regeneration and chick development in international peer-review journals. 
Corresponding 
address 
Victor Hernández, Departament de Genètica, Facultat de Biologia, Universitat de 
Barcelona, Av. Diagonal 645, 08028 Barcelona, Catalonia, SPAIN. Tel: 34-93-402.15.00 
/ 34-93-403.70.70. e-mail: victorhernandez@ub.edu 
Int. J. Biol. Sci. 2005 1: 1-12 2
1. Introduction 
The in ovo accessibility of the chick embryo makes it a favoured model system for in vivo studies of 
developmental processes. Since the development of in ovo gene transfer by electroporation [1], it has 
been possible to analyse the function of a gene by overexpressing it in specific tissues. However, it is 
still difficult to knock out the function of a gene of interest because it is not yet possible to make mutant 
animals by gene targeting. Recently however, the possibility of silencing gene expression by RNA 
interference (RNAi) has been reported. 
RNAi is thought to be an evolutionarily conserved process that responds to the presence of 
double-stranded RNA (dsRNA) [2, 3, 4, 5]. The mechanism through which RNAi functions is based on 
the action of a set of enzymes that cleave the dsRNA into small interfering 21-23mer RNAs (siRNA) 
that act as templates for the specific degradation of the corresponding mRNAs [3, 6, 7, 8]. The key 
enzyme in this process is Dicer, a Ribonuclease III family molecule containing a PAZ domain and two 
dsRNA binding domains [9]. 
RNAi has been successfully used in several invertebrates, e.g. in C. elegans and Drosophila, both 
through dsRNA and constructs expressing siRNA [10, 11, 12, 13, 14]. It was initially postulated that this 
technique could not be used in vertebrates because the intracellular presence of dsRNA may trigger an 
antiviral response mediated by a dsRNA-dependent protein kinase (PKR) and the interferon system, 
which inhibits transcription [15]. However, the discovery of siRNAs, which are thought to escape the 
PKR, raised the possibility of using RNAi in vertebrates, although there are some reports suggesting 
that in mammalian cells siRNAs may actually upregulate some interferon response genes [16, 17]. 
Several recent papers have suggested that RNAi is effective in zebrafish, mouse and chick 
embryos. In zebrafish, Wargelius [18] and Li [19] reported the application of RNAi by injecting dsRNAs 
at 1-2 cell stage. However, Oates [20], using dsRNAs from several genes, were not able to distinguish 
the phenotypes produced by them, suggesting a non-specific effect of dsRNA on gene silencing. In 
mice, the use of RNAi has been reported in cultured cell lines [21, 22, 23], in oocytes [24, 25], and in 
embryos [23, 26, 27]. In these studies, the expression of the gene to be silenced was only partially 
reduced in a population of cells, and no morphological alterations were reported, with the exception of 
a mild mutant phenotype observed in the derivates of some oocytes when compared with 
corresponding null mutants [23]. 
Finally, although the few published works on RNAi in chick embryos are very optimistic, they 
show discrete quantitative differences in the expression of endogenous target genes and limited, if any, 
morphological alterations [28, 29, 30, 31]. It is important to note that in all of these studies the 
transfection efficiency was assessed by using independent reporter plasmids as markers, thereby 
precluding the identification of the individual cells containing the molecules that trigger RNAi. 
We have performed several experiments to elucidate whether the currently available tools are 
adequate to silence gene expression in chick embryos to a sufficient extent to produce a clear and 
specific null-like mutant phenotype using internal markers for siRNA and shRNA localisation. These 
experiments focused on RNAi of fgf8 in the isthmus. Fgf8 is a member of the fibroblast growth factor 
gene family, which codes for ligands that act to promote the growth and differentiation of many 
mesodermal and ectodermal cells by binding to specific receptors. Its expression is spatially regulated 
during development, e.g. in the isthmic organizer [32, 33]. The isthmic organizer, located at the mid-
hindbrain boundary, exhibits a morphogenetic activity that acts on the midbrain neuroectoderm [34, 
35]. Both fgf8 hypomorph homozygote mutant mice and zebrafish acerebellar mutants, which carry a 
mutation affecting fgf8, lack posterior midbrain and cerebellar tissue [36, 37, 38]. 
We microinjected different potential triggers for RNAi into the neural tube: fgf8 dsRNA; a pool of 
siRNAs to fgf8 obtained in vitro by Dicer-digestion, some of which were labelled with digoxigenin 
(DIG) to monitor their uptake at a cellular level; and the psiRNA-hH1GFPzeo G2 plasmid engineered to 
express short hairpin RNAs (shRNAs) to fgf8. The shRNA-producing vector also expresses green 
fluorescent protein (GFP) as an internal transfection marker. Although our results are basically in 
agreement with previously reported studies on the silencing of endogenous genes in chick embryos, i.e. 
some cells expressing shRNA to fgf8 may show a reduction in fgf8 expression, we suggest that the 
currently available tools and techniques are inadequate to generate a detectable mutant fgf8 phenotype 
at the embryo level, thus making RNAi useless as a routine method to study gene function in chick 
embryos. 
2. Materials and methods 
Production of dsRNA and in vitro Dicer-digestion 
Fgf8 dsRNA was produced from a fragment of cDNA encoding fgf8b cloned in pBluescript KS [39]. 
After linearization with EcoRI or XhoI, RNA synthesis was carried out in vitro from T7 and T3 
promoters for antisense and sense RNAs respectively. For each direction, 2 µg DNA was mixed with a 
final concentration of 4mM rNTPs or DIG-rNTPs (Roche) to synthesise dsRNA or DIG-labelled dsRNA 
respectively, and with the appropriate concentration of T3 and T7 polymerases (Roche). After 2 h 
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transcription at 37ºC for the T7 promoter and 25ºC for T3 promoter (to produce equimolar 
concentrations), 1 µl of DNAse I (Roche) was added and the mixture incubated for 15 min at 37ºC. The 
reaction was stopped with 380 µl of STOP solution (1M NH4OAc, 10mM EDTA, 0.2% SDS). The RNA 
was extracted first with phenol:chloroform 1:1 (v/v) and then chloroform. Equal amounts of sense and 
antisense RNA from the aqueous layer were mixed, heated to 70ºC for 10 min and annealed at 37ºC for 
30 min. After precipitation in ethanol, the dsRNA was dissolved in 10 µl of DMEM (Gibco) 
supplemented with 0.3 µg/ml Vital Red/DMEM to visualize microinjection, or in 10 µl of H20 for in 
vitro Dicer-digestion. For quality control, 1µl of each sample was analyzed by gel electrophoresis (0.8% 
agarose). 
To obtain a pool of siRNAs or DIG-labelled siRNAs from fgf8 dsRNA, dsRNA or DIG-labelled 
dsRNA dissolved in H20 were digested and purified using the Dicer Kit (Gene Therapy Systems), 
according to the manufacturers instructions. For quality controls, samples were analyzed by gel 
electrophoresis (3% agarose). The efficiency of in vitro Dicer-digestion of DIG-dsRNAs was also tested 
on an agarose gel, showing no differences with respect to control siRNAs (Fig. 1). 
Plasmids and shRNA constructs 
To monitor siRNA electroporation efficiency we used a GFP expression vector (pEGFP-C2, 
Clontech; see below). The shRNAs used to interfere with fgf8 expression were designed according to 
the general rules of the siRNA WizardTM program (Invivogen; www.invivogen.com), and the 
interfering sequence was cloned into the psiRNA-hH1GFPzeo G2 vector (Invivogen). This vector 
coexpresses the cloned shRNA, under the control of the H1 promoter, with GFP, under the control of 
the hEF1/HTLV promoter and SV40 enhancer (Fig. 2A). 
Two sets of 21-mer oligonucleotides were selected from the fgf8b open reading frame (ORF) 
sequence. The 21-mer sense and antisense RNA sequences were linked to a seven nucleotide spacer 
(TCAAGAG) as a loop, and nucleotides corresponding to HindIII and Acc65I restriction sites were 
added to the 5’ and 3’ end of the reverse oligonucleotides respectively. The engineered DNAs for the 
corresponding shRNAs are shown in Fig. 2B. They were annealed and cloned into the psiRNA-
hH1GFPzeo G2 vector using the HindIII/Acc65I restriction sites. Following the instructions of the 
plasmid supplier, vectors were transformed into the E.coli strain GT116, in which sbcC and sbcD genes 
are deleted, to increase shRNA stability. 
In ovo microinjection and electroporation 
Fertilized eggs obtained from a local farm (Granja Gibert) were incubated at 38ºC and windowed 
using Scotch tape. They were staged according to Hamburger and Hamilton [40]. DsRNA, the pool of 
siRNAs or the shRNA-producing plasmid were microinjected into the neural tube of embryos at HH 9-
11 using a Drummond piston microinjector (32 nl at 3-5 µg/µl). Embryos were contrasted with 0.3 
mg/ml Fast Green (Sigma) solution, and the pool of siRNAs and the plasmid producing shRNA were 
mixed with Fast Green at 3 mg/ml (3:1 v/v) prior to microinjection to monitor their localisation in the 
neural tube. Just after microinjection, the pool of siRNAs and the shRNA-producing plasmid were 
electroporated using a TSS20 Ovodyne electroporator (Intracel; 25V, 50ms pulse-width, 5 pulses with 
30ms intervals between the pulses) and platinum electrodes (Nepagene; 5mm in length, 0.5mm wide) in 
0.01x PBS as electroporation medium. After electroporation, the embryo was covered with DMEM 
(Gibco), the window was sealed with Scotch tape and the egg was incubated at 38ºC. The pool of 
siRNAs was co-electroporated with pEGFP-C2 (U57606) to assess electroporation efficiency and 
localisation. As described previously [41, 42], transfection occurs on one side of the neural tube, the 
other side serving as a control. 
In situ hybridisation, immunohistochemistry and TUNEL assay 
Embryos were fixed overnight (ON) at 4ºC in 4% paraformaldehyde in 1xPBS, dehydrated in a 
methanol series and stored at -20ºC prior to use. In situ hybridisation was performed as described by 
Bueno et al. [43] for single probe development, with minor modifications (hybridisation temperature 
was 55ºC, and the incubation time of the anti-DIG antibody was 3 hours at room temperature). The Fgf8 
construct used to produce the antisense riboprobe was from Crossley et al. [39]. The α−peptide 
construct for antisense riboprobe production was generated by PCR cloning of 237 nt of the α−peptide 
sequence into pBluescript KS (EcoRI/XhoI restriction sites). The primers used were the following: 
forward 5'ccggaattcatggaccctgttgtgctgcaa3' and reverse 5'ccgctcgagcacagtgtcagcctctgggag3'. Antisense 
riboprobe was transcribed with T7 polymerase after EcoRI digestion. 
As in situ hybridization treatments destroy GFP fluorescence, immunohistochemistry with a 
polyclonal antibody to GFP (Molecular Probes) was performed to detect its presence after fgf8 in situ 
hybridisation. Briefly, hybridised embryos were post-fixed at 4ºC for 2 hours with 4% 
paraformaldehyde in 1xPBS. For immunohistochemistry on sections, the embryos were dehydrated in 
an ethanol series, passed through xylene and embedded in paraffin. 10 µm sections were dewaxed in 
xylene and rehydrated in an ethanol series. For both immunohistochemistry on sections and on whole 
mount embryos, samples were blocked and incubated with the anti-GFP antibody, at 1/250 or 1/500 
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respectively, for 48 h at 4ºC. After extensive washes, samples were incubated with a FITC-conjugated 
donkey anti-rabbit polyclonal antibody (Molecular Probes). 
To detect the presence of DIG-labelled siRNAs, embryos were processed as for in situ 
hybridisation. After permeabilisation, they were blocked, incubated with an anti-DIG antibody (Roche) 
and developed with NBT/BCIP. 
Apoptotic cells were detected by TUNEL assay on whole mount embryos using standard 
procedures. Briefly, embryos were fixed overnight at 4ºC in 4% paraformaldehyde and permeabilised 
with PBT (PBS + 0.1% Triton X-100 + 0.1% Sodium Citrate). The 3'-OH ends of DNA were labelled for 
two hours at 37ºC by addition of digoxigenin 11-UTPs using the enzyme TdT. Then, the samples were 
blocked, the presence of DIG was detected with an anti-DIG antibody coupled to alkaline phosphatase 
and they were developed with NBT/BCIP. 
3. Results 
dsRNA microinjection into the neural tube 
First of all, to test whether dsRNA triggers specific gene silencing in chick embryos, as reported for 
invertebrates, fgf8 dsRNA was microinjected into the neural tube of embryos at HH9-11. After 24 h or 
48 h of in vivo (in ovo) embryonic development, i.e. at HH18-20 or HH23-24 respectively, embryos were 
killed and examined under the dissecting microscope to search for morphological defects, especially at 
the midbrain/hindbrain junction. In these experiments no morphological defects were observed, as 
compared with control embryos (not shown). 
To examine whether fgf8 expression was silenced in these embryos, whole mount in situ 
hybridization with an fgf8 ribroprobe was performed. Fgf8 expression was detected in all 
neuroepithelial areas where it has previously been reported to be expressed, i.e. the isthmus and the 
frontal end of the telencephalon, as well as in the other embryonic sites, e.g. the eyes, branchial arches, 
the narrow pit and the apical ectodermal ridge of the limbs in HH23-24 embryos, as in control embryos 
(not shown). Finally, careful microscopic examination of serial sections from the hybridized embryos 
revealed no subtle morphological defects in the neuroectoderm (not shown).  
Electroporation of siRNAs into the isthmus and RNAi spreading 
To force the penetration of the putative triggering molecules for fgf8 gene silencing, a pool of 
siRNAs to fgf8 obtained in vitro by Dicer-digestion from the corresponding dsRNA was microinjected 
into the neural tube of embryos at HH9-11 and immediately electroporated into the isthmic cells. In 
these experiments the siRNAS were co-injected and co-electroporated with the pEGFP-C2 plasmid as 
an independent marker of electroporation efficiency. After 24 h of in vivo development the embryos 
were killed. Those embryos showing GFP fluorescence on the electroporated side of the isthmus were 
examined under the dissecting microscope to search for morphological defects. Again, no defects were 
observed when compared with control embryos (Fig. 3, and data not shown). 
To examine whether fgf8 was silenced on the electroporated side of the isthmus, whole mount in 
situ hybridization with an fgf8 ribroprobe was performed. Fgf8 expression showed no significant 
differences between the two sides of the isthmus. Careful microscopic examination of serial sections 
from the hybridized embryos did not reveal any subtle morphological defect (not shown). 
As the pEGFP-C2 plasmid has a different size and overall structure to the siRNAs (circular 4.7kb 
or linear 21mers respectively) that may affect the electroporation efficiency, we monitored whether the 
isthmic cells had actually been transfected with the siRNAs by using DIG-labelled siRNAs. The DIG-
siRNAs were also co-injected and co-electroporated together with the pEGFP-C2 plasmid. After 24 h of 
in vivo embryonic development embryos showing GFP fluorescence on the electroporated side of the 
neural tube were immunostained with an antibody to DIG. Most of the GFP positive cells also showed 
the presence of siRNAs in their cytoplasm (Fig. 3). Interestingly, no significant spreading of the siRNAs 
from the transfected cells was observed. From these experiments we conclude that the electroporation 
profile used is appropriate for the transfection of the siRNAs, and thus that electroporation of a pool of 
siRNAs to fgf8 is not able to silence fgf8 expression in the isthmus. 
Electroporation of a plasmid producing shRNAs 
To test the possibility that the results obtained by electroporation of a pool of siRNAs were due to 
an insufficient number of siRNA molecules per cell to trigger the degradation of all existing and newly 
synthesised fgf8 mRNA molecules, the psiRNA-hH1GFPzeo G2 shRNA-producing plasmid was 
microinjected into the neural tube and electroporated into the isthmus. 
First of all we tested whether the H1 promoter for the shRNA was properly directing the 
expression of the downstream cloned sequences in chick embryos. Wild type plasmids, which carry the 
α-peptide sequence of the β-gal gene located under the control of the H1 promoter, were microinjected 
and electroporated into the isthmus. After 12 h or 24 h of in vivo development, embryos showing GFP 
fluorescence on the electroporated side of the isthmus were hybridized with a riboprobe to the α-
peptide. These embryos exhibited a very high level of α-peptide expression (Fig. 4), suggesting that the 
H1 promoter also directs the expression of the shRNAs in the cells of the chick neural tube. In this way 
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the number of shRNA molecules present in each particular cell will be much higher than the number of 
siRNA molecules electroporated after Dicer-digestion of the corresponding dsRNA. Moreover, this 
experiment also proved that both promoters (i.e. H1 promoter for the shRNA and hEF1/HTLV 
promoter for GFP) were working simultaneously, with no interferences. 
Two different shRNAs to fgf8, the best shRNAs to silence fgf8 expression according the general 
rules of the siRNA WizardTM program (Invivogen), were engineered and independently cloned into the 
psiRNA-hH1GFPzeo G2 plasmid. These constructs were either independently or simultaneously 
microinjected and electroporated into the isthmus of chick embryos at HH9-11, in order to maximize 
the possible gene silencing effect. After 24 h of in vivo development, embryos showing GFP fluorescence 
on the electroporated side of the isthmus were examined under the dissecting microscope to search for 
morphological defects. Once again, no morphological defects were observed, as compared with control 
embryos electroporated with the wild type plasmid (Figs. 5 and 6). To examine whether fgf8 expression 
was silenced on the electroporated side of the isthmus, whole mount in situ hybridization with an fgf8 
ribroprobe was performed. Fgf8 expression examined at whole embryo level showed a slight decrease 
on the electroporated side of the isthmus as compared with the control side (Figs. 5 and 6), although 
careful microscopic examination of serial sections from the hybridized embryos did not reveal any 
subtle morphological defect (Figs. 5 and 6). 
To check whether fgf8 expression was actually silenced in the transformed cells, 
immunohistochemistry with an antibody to GFP was performed on whole mount embryos and on 
sections after fgf8 in situ hybridization. This experiment allowed us to visualize individual transfected 
cells and fgf8 expressing cells simultaneously. Although some GFP positive cells were clearly not 
expressing fgf8, most of the transfected cells did, suggesting that if RNAi occurs in chick embryos, its 
efficiency is very low (Fig. 7). 
Finally, as it has been reported that dsRNA and siRNA molecules may trigger an apoptotic 
response in vertebrate cells that may mask and/or simulate RNAi effects, we monitored apoptosis to 
check whether the slight decrease in fgf8 expression was caused by the death of some of the transfected 
cells. The pattern of apoptotic cells in adjacent non-transfected structures of the electroporated side as 
the eye and the otic vesicle were used as controls. Embryos electroporated with the shRNA-producing 
plasmid showed few apoptotic cells that affect mostly the ectoderm, and no significant differences were 
observed between these embryos and either control embryos electroporated with the wild type plasmid 
or non-electroporated embryos (Fig. 8). 
4. Discussion 
We have analysed the possible use of RNAi as a routine method for specific gene silencing in chick 
embryos by assessing the capacity of different potential triggers of RNAi (dsRNA, a pool of siRNAs 
obtained in vitro by Dicer-digestion of the corresponding dsRNA, and a plasmid producing shRNA to 
the gene to be silenced) to silence fgf8 expression in the isthmus, as well as to provoke morphological 
malformations in midbrain/hindbrain junction derivates.  
Action of RNAi 
All published studies focused on the possible use of RNAi to silence gene expression in chick 
embryos, in which dsRNA molecules or non-viral vectors producing shRNAs have been electroporated 
into target cells, have taken advantage of the sealed cavity of the neural tube to introduce the putative 
trigger molecules prior to electroporation [28, 29, 31]. To facilitate the experimental manipulation of the 
embryos we also introduced the putative trigger molecules for RNAi into the neural tube. We have 
focused on fgf8 expression in the isthmus to monitor gene silencing for several practical reasons. Firstly, 
the isthmus is easily accessible from the neural cavity, and clearly recognizable under a dissecting 
microscope to properly localize the molecules that trigger RNAi. Secondly, when the neural tube is 
completely sealed, at HH9, fgf8 expression in the isthmus is still faint and is detected in relatively few 
cells that are restricted to a small area [32, 33], a fact that may facilitate the degradation of all existing 
mRNA molecules. And thirdly, the phenotype of fgf8 null-mutant and allelic series of mutations 
affecting the isthmus has been reported in other vertebrate model systems, and is easily 
morphologically recognizable as a deletion of the isthmus derivatives [36]. 
We observed no morphological defects in any of the experiments performed. We have also shown 
that fgf8 expression is neither silenced in embryos microinjected with dsRNA nor in embryos 
microinjected and electroporated with a pool of siRNAs. Moreover, fgf8 expression is also not 
significantly silenced in most isthmic cells transformed with the psiRNA-hH1GFPzeo G2 plasmid 
producing the engineered shRNAs to fgf8, and an increase in cell death is not detected either in the 
transfected neuroectoderm or in adjacent structures serving as controls for the possible toxic effects of 
the electric field.  
Our results are basically in agreement with previously reported studies on RNAi of endogenous 
genes in chick embryos. Thus, the electroporation of a pSilencer 1.0-U6 vector (Ambion) producing 
shRNA to en-1 or en-2 [29] or to Islet1 [31] does not produce any recognizable morphological defect and 
only a discrete reduction of gene expression. In apparent contrast, electroporation of dsRNA to axonin-1 
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and NrCAM, which are involved in axonal guidance, produces some morphological defects affecting 
this process in 20% of the neurons [28], although the possibility that this arises from an increase in cell 
death due to the presence of dsRNA molecules was not analysed. Nevertheless, the presence of just 
20% of affected neurons is unlikely to be sufficient to see any long-term defect, as in many cases 
embryos are able to balance mild developmental defects. 
In a similar way, microinjection of the viral pSuper vector (OligoEngine) engineered to produce 
shRNA to silence mkp-3 expression in the limb bud mesenchyme [30] caused an increase in cell death 
compared with controls microinjected with an RCAS virus expressing GFP, although unfortunately no 
other shRNAs were used to assess the non-specific effect of these molecules on cell death in the limb 
mesenchyme. 
In these studies the electroporation efficiency and the localisation of the molecules that may trigger 
RNAi were assessed by co-electroporation of an independent reporter plasmid, thereby precluding 
analysis of which particular cells were effectively transfected with the RNAi triggering molecules. This 
is especially important when considering that a maximum of 60% of the cells of the electroporated side 
are actually transfected with the reporter plasmid [28]. This handicap is avoided with the psiRNA-
hH1GFPzeo G2 plasmid used in this study, as it coexpresses GFP as a marker. This allowed us to 
clearly determine that although some transfected cells do not express fgf8, most of them do. This raises 
the question of whether the reduction of fgf8 expression in some transfected cells occurs irrespective of 
the presence of the specific shRNA, or instead whether the presence of shRNA is triggering gene 
silencing only in certain cells due to an unknown intrinsic difference between them. Nevertheless, the 
small reduction in gene expression, if any, accounts for the lack of morphological defects in RNAi 
treated embryos. 
A similar situation occurs in mice [21, 22, 23, 24, 25, 27]. Here, with the exception of a mild 
phenotype reported by Paddison et al. [23] in the derivates of some oocytes, no phenotypic alterations 
have been reported. 
Better results are obtained when attempting to silence the expression of exogenous genes in chick 
embryos, although the gene silencing is incomplete, Pekarik [28] reported that co-electroporation of a 
vector expressing yellow fluorescent protein (YFP) together with dsRNA to YFP in the neural tube 
causes a reduction of YFP fluorescence in a substantial number of cells. Moreover, Chesnutt and 
Niswander [31] also reported a significant but incomplete reduction of GFP expression when co-
electroporating a vector expressing GFP and a pSilencer 1.0-U6 vector expressing shRNA to this gene. 
Taking into account our results and the published works discussed above, we suggest that the 
currently available tools and techniques for RNAi are not suitable as a routine method for functional 
gene analysis in chick embryos, as it is in some invertebrates [11, 12, 13, 14]. This suggestion does not 
preclude a possible use of RNAi to analyze the effect of gene silencing at a molecular level in individual 
transfected cells, the ones that may show a reduction in gene expression.  
Is RNAi an evolutionarily conserved mechanism? 
Although it is commonly said that RNAi is an evolutionarily conserved mechanism, reports of 
molecular differences between several model systems are appearing. Thus, most invertebrates in which 
RNAi has been successfully used are able to take up dsRNA molecules by themselves, the exception 
being Drosophila. The molecule responsible for dsRNA uptake and siRNA spreading is SID-1, a specific 
transmembrane protein [44, 45, 46]. Drosophila shows RNAi but lacks a sid-1 ortholog, thus not showing 
the spreading characteristic [45, 47]. In this way, the amount of dsRNA needed for RNAi in this 
organism is 10,000 times higher than in controls expressing sid-1 ectopically. 
The presence of sid homologs has been reported in mice, although these organisms do not seem to 
be able to take up dsRNA by themselves, a similar situation occurring in chick embryos. In fact, all 
reports on the use of dsRNA or siRNA for RNAi in vertebrates have forced these molecules to enter the 
cells, either by calcium precipitation, electroporation or cytoplasmic microinjection. Moreover, our 
results have also shown that siRNA molecules do not spread from the transfected cells to the rest of the 
tissue or the embryo, as has been reported to occur in most invertebrates [2], suggesting the existence of 
molecular differences between different model systems that may explain the different responses to 
RNAi. To develop a general procedure for RNAi in chick embryos for routine functional gene analysis, 
if it is technically and molecularly possible, a better knowledge of the mechanisms leading to gene 
silencing in vertebrates is needed. 
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Figures 
Figure 1. siRNA and DIG-siRNA obtained by in vitro Dicer-digestion. A 3% agarose gel electrophoresis of 
siRNA and DIG-labelled siRNA to fgf8 is shown. Note that Dicer is able to generate a pool of siRNAs from both 
dsRNA and DIG-labelled dsRNA. 
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Figure 2. Plasmids and shRNA constructs. A) Wild-type psiRNA-hH1GFPzeo G2 vector map showing 
Acc65I/HindIII restriction sites (*), the α-peptide coding sequence located downstream of the H1 promoter, and 
the GFP coding sequence located downstream of hEF1-HTLV promoter. B) Engineered DNA oligonucleotides for 
the shRNAs: 21-mers are shown in green; the spacer is shown in blue; HindIII and Acc65I restriction sites are 
shown in orange; and the poly-A sequence is shown in black. The presumptive secondary structure of shfgf8b-1 is 
also shown. 
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Figure 3. Localisation of DIG-siRNA 24 h after electroporation. Embryos co-electroporated with a pool of 
DIG-labelled siRNAs and the pEGFP-C2 plasmid. A) GFP fluorescence into the electroporated side of the neural 
tube before DIG immunodetection 
(arrows). Yellow dashed line is delimiting 
the GFP expression area. B) GFP 
fluorescence into the electroporated side 
of the neural tube of the embryo shown in 
A) after DIG immunodetection (arrows). 
Note a decrease in GFP fluorescence due 
to the presence of the NBT/BCIP 
precipitate. C) Immunodetection of DIG-
labelled siRNA in the neural tube (in blue; 
arrows) in the same embryo than A) and 
B). D) Merging of B) and C). Yellow 
dashed line has been extrapolated from A) 
and is delimiting the area of GFP 
expression before NBT/BCIP 
precipitation. Note that most cells 
exhibiting GFP fluorescence also show 
the presence of the DIG-siRNAs, although 
they do not colocalize in all electroporated 
cells. Also note the absence of siRNA 
spreading from the electroporated area. 
Abbreviations: Ist, isthmus; Oc, optic cup; Tel, telencephalon. 
 
Figure 4. α-peptide expression in 
embryos transfected with the psiRNA-
hH1GFPzeo G2 vector. A-B) Two 
different embryos 12 h after 
electroporation hybridised with the α-
peptide antisense riboprobe. Note the 
expression of the α-peptide sequence in 
the electroporated half-side of the neural 
tube (arrows). C-D) Two different 
embryos 24 h after electroporation 
hybridised with the α-peptide antisense 
riboprobe. Note that the expression of the 
α-peptide is properly localized into the 
isthmus (arrows). E) Facial view of the 
embryo shown in D. Note that the α-
peptide is expressed only in electroporated 
side (arrowhead). 
 
 
 
 
 
 
 
Figure 5. Fgf8 and isthmic morphology 
in flattened isthmus of embryos 
transfected with shfgf8b-1 and shfgf8b-2. Dorsal view of a 
flattened isthmus hybridised with the fgf8 riboprobe 24 h after 
plasmids electroporation. The black line follows the dorsal 
midline. Note that no significant differences either in fgf8 
expression or neuroectoderm morphology are observed when 
comparing both sides of the isthmus. 
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Figure 6. Fgf8 expression and 
isthmic morphology in whole 
mount embryos transfected 
with shfgf8b-1 and shfgf8b-2. 
Rostral is to the left. A) Embryo 
24 h after electroporation, prior 
to fgf8 in situ hybridisation. Note 
that the morphology of the 
isthmic derivatives is completely 
normal (compare with control 
embryo shown in C). A') 
Magnification of A) showing the 
isthmic area. B) GFP 
fluorescence (arrowheads) in the 
electroporated side of the same 
embryo shown in A). B') 
Magnification of B) showing the 
area of GFP expression 
(arrowheads). C) Fgf8 in situ 
hybridisation of a control 
embryo. D) Fgf8 in situ 
hybridisation in the isthmus of 
the embryo shown in A) (arrow). 
Note that fgf8 expression in the 
isthmus is very similar to that 
shown in C). Abbreviations: 
AERfl, forelimb apical 
ectodermal ridge; AERhl, 
hindlimb apical ectodermal 
ridge; BA, branchial arches; Ist, 
isthmus; Met, metencephalon; 
Mes, mesencephalon; Tel, 
telencephalon. 
 
Figure 7. Fgf8 expression and 
isthmic morphology in sections of embryos transfected with shfgf8b-1 and shfgf8b-2. Transversal sections of 
the neural tube at the isthmus level. Both sides of neural tube are shown. The electroporated side is to the left. A) 
Fgf8 expression detected by in 
situ hybridisation. B) GFP 
expression in the same section 
shown in A) detected by GFP 
immunostaining. Note that GFP 
is detected only in the 
electroporated side (arrowheads). 
C) Merging of A) and B). The 
expression of fgf8 is very similar 
in electroporated and control 
neuroepithelium. D to F) 
Magnification of sections shown 
in A to C respectively. Note the 
presence of cells showing fgf8 
and GFP expression 
simultaneously (arrows and 
arrowhead). G to I) 
Magnification of sections shown 
in A to C respectively in a 
different focal plane. Note the 
presence of cells showing GFP 
expression but not fgf8 
expression (double arrowhead). 
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Figure 8. Apoptosis in embryos transfected with shfgf8b-1 and shfgf8b-2. A) Dorsal view of a transfected 
embryo in which apoptotic cells have been detected by TUNEL assay (brown nuclei). Note the absence of 
morphological defects (the transfected side is to the bottom). B) GFP fluorescence in the same embryo. The 
transfected area includes the isthmus. C) Merging of B) and C). D) Magnification of the isthmic area of A). Note 
that both sides of the embryo exhibit a similar amount of apoptotic cells (arrows), which affect mostly the 
ectoderm. E) Magnification of the isthmic area of B). The arrow points an apoptotic cell not expressing GFP. F) 
Magnification of the isthmic area of C). G)  Dissected cephalic cavity showing the internal side of the 
mesencephalon, the metencephalon and the isthmus. Apoptotic cells have been detected by TUNEL assay (brown 
nuclei). The morphology of the transfected side (left hand side) is completely normal, and that apoptotic cells are 
equally distributed at both sides of the embryo. H) GFP fluorescence in the same embryo. The transfected area 
includes the isthmus. I) Merging of G) and H).  J) Apoptosis control in the eye of the electroporated side. Note 
that apoptotic cells are located in the dorsal portion of the optic cup as described in the literature for normal 
embryos (Trousse et al., 2001). K) Apoptosis control in the ear of the electroporated side. Note that apoptotic cells 
are located in the dorsal portion of the otic vesicle as described in the literature for normal embryos (Lang et al., 
2000). Abbreviations: Ant, anterior; Mes, mesencephalon; Met, metencephalon; Pos, posterior. 
 
 
